Dr. Love obtained her doctorate from the University of Missouri, Kansas City in pharmaceutics, with an emphasis in pharmacology. She has over 35 years’ experience in both in vitro and in vivo pharmacology models in both small and large animals. During her career, she has held positions at the University of Missouri - Columbia, University of Kansas Medical Center, Marion Laboratories, Marion Merrell Dow, Quintiles, Aptuit, Lytmos and Grant Management Group, and Xenometrics LLC. She joined Charles River through the acquisition of Citoxlab, bringing expertise in early drug discovery screening, determination of compound mechanism of action, metabolism studies, efficacy testing, disease models, lead selection/early development studies, and preclinical GLP IND-enabling safety pharmacology, and follow-up studies. She has special interest in the fields of cardiovascular physiology/pharmacology, CNS, respiratory, and GI systems.
Sandra Love, PhD
Director, Safety Pharmacology